Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares Issued
Ratios

BioScience Health Innovations (BHIC) Long-Term Debt Issuances (2019 - 2025)

BioScience Health Innovations (BHIC) has disclosed Long-Term Debt Issuances for 6 consecutive years, with $623984.0 as the latest value for Q4 2025.

  • Quarterly Long-Term Debt Issuances rose 131.02% to $623984.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2025, up 144.11% year-over-year, with the annual reading at $3.0 million for FY2025, 216.36% up from the prior year.
  • Long-Term Debt Issuances for Q4 2025 was $623984.0 at BioScience Health Innovations, down from $802119.0 in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $802119.0 in Q2 2025, with the low at $1200.0 in Q2 2021.
  • Average Long-Term Debt Issuances over 4 years is $302857.7, with a median of $244818.5 recorded in 2023.
  • Peak annual rise in Long-Term Debt Issuances hit 215.81% in 2024, while the deepest fall reached 5.18% in 2024.
  • Over 4 years, Long-Term Debt Issuances stood at $1693.0 in 2021, then soared by 15068.34% to $256800.0 in 2023, then rose by 5.18% to $270102.0 in 2024, then skyrocketed by 131.02% to $623984.0 in 2025.
  • According to Business Quant data, Long-Term Debt Issuances over the past three periods came in at $623984.0, $802119.0, and $589516.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.